Abstract
Deaths and transmission from malaria have declined significantly in the past decade, although the progress has somewhat stalled in recent years [1]. Accurate and timely diagnosis is essential to providing adequate treatment to malaria cases. Plasmodium falciparum histidine-rich protein 2 (PfHRP2) based rapid diagnostic test (RDT) is widely used especially in Africa, where P. falciparum accounts for 98% of estimated malaria cases [1]. Despite its importance, reports of parasites lacking pfhrp2 gene emerging across the globe are threatening the importance of this malaria diagnostic tool.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
